ERBB2 and neoplasm: This subtype is characterized by the overexpression of the human epidermal growth factor receptor 2 (HER2) protein, which is historically associated with tumor aggressiveness and poor prognosis, with an increased risk of recurrence, metastasis, and mortality [1].